The Indianapolis Colts have confirmed that the Federal Bureau of Investigation (FBI) has launched an investigation into the death of team owner Jim Irsay. The announcement, made on Thursday, follows reports that a California-based physician who allegedly prescribed painkillers and ketamine to Irsay may be connected to the circumstances surrounding his passing.
Jim Irsay, who served as the Colts’ owner since 1997 after succeeding his father, Robert Irsay, had overseen significant periods in the franchise’s history, including the Peyton Manning era and the team’s Super Bowl XLI victory in 2007. Known for his outspoken personality and deep connection to the organization, Irsay had faced recurring public health challenges, including struggles with substance use.
The team released a brief statement acknowledging the federal probe, stating they are cooperating with authorities and offering no further comment due to the ongoing nature of the investigation. The FBI has not publicly released specific details about the case or potential charges, and no formal allegations have been brought forward against the physician in question as of now.
The circumstances surrounding Irsay’s death remain under review by federal authorities. Medical professionals prescribing controlled substances are frequently subject to oversight and investigation when questions arise related to the misuse or improper distribution of medications such as opioids or ketamine.
Irsay’s death has prompted renewed focus on mental and physical health support for NFL executives and players alike. The league and the Colts organization have expressed condolences to the Irsay family while urging privacy as the investigation continues.
Further updates are expected as authorities continue to collect evidence and interview relevant parties. Meanwhile, the Colts are navigating the transition process in ownership and management, with details about the team’s future leadership expected to emerge in the coming weeks.
No timeframe has been given for the completion of the federal probe.
